Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-04-22 @ 5:39 PM
Study NCT ID:
NCT00749034
Status:
COMPLETED
Last Update Posted:
2010-05-20
First Post:
2008-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male Volunteers
Sponsor:
Serum Life Science Europe GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VPM1002-GE-1.01TB
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr. Hans-Heinrich Henneicke - v. Zepelin / CPM
Old Organization:
Vakzine Projekt Management GmbH